Choi Minji, Sultana Tamanna, Park Myeongki, Lee Byong-Taek
Department of Regenerative Medicine, College of Medicine, Soonchunhyang University, Cheonan 31151, Republic of Korea.
Institute of Tissue Regeneration, Soonchunhyang University, Cheonan 31151, Republic of Korea.
Mater Sci Eng C Mater Biol Appl. 2021 Jan;120:111659. doi: 10.1016/j.msec.2020.111659. Epub 2020 Oct 21.
Biomaterials to be used for vascular tissue engineering must allow attachment, proliferation, and functionalization of vasoactive cells especially endothelial cells. In this study, decellularized L929 fibroblast cell-derived ECM containing electrospun scaffolds were fabricated and their biological response was investigated using rat glomerulus endothelial cells (rGECs). The L929 cells were grown for one week to get cell sheets on PCL membranes followed by decellularization of whole cell sheet-PCL membrane (PCL-ECM) using sodium dodecyl sulfate (SDS)/triton X-100 (TX) or freeze/thaw (F/T)/Deoxyribonuclease cycle to yield the corresponding mechanically stable scaffold. The nucleic acids and structural proteins quantification were performed on various membranes before and after decellularization process. Seeded rGECs on PCL, PCL-ECM (SDS/TX) and PCL-ECM (F/T) membranes were investigated through immunofluorescence and cell proliferation assay. The bio-macromolecules contents on decellularized scaffolds showed diverse outcome because of different decellularization methods used. The hydrophilic PCL-ECM (F/T) scaffold showed the best result by ensuring stability, good cytocompatibility, and interconnections among endothelial cells as was further confirmed by endothelial gene expression analysis. In short, the outcomes of this study may pave the way for the construction of new cell-derived ECM based vascular tissue engineering scaffolds as well as for the development of in vitro models to study endothelial cell function.
用于血管组织工程的生物材料必须允许血管活性细胞尤其是内皮细胞附着、增殖并实现功能化。在本研究中,制备了含有静电纺丝支架的脱细胞L929成纤维细胞衍生的细胞外基质(ECM),并使用大鼠肾小球内皮细胞(rGECs)研究了其生物学反应。将L929细胞培养一周以在聚己内酯(PCL)膜上形成细胞片,然后使用十二烷基硫酸钠(SDS)/曲拉通X-100(TX)或冻融(F/T)/脱氧核糖核酸酶循环对整个细胞片-PCL膜(PCL-ECM)进行脱细胞处理,以产生相应的机械稳定支架。在脱细胞处理前后,对各种膜进行核酸和结构蛋白定量分析。通过免疫荧光和细胞增殖试验研究接种在PCL、PCL-ECM(SDS/TX)和PCL-ECM(F/T)膜上的rGECs。由于使用了不同的脱细胞方法,脱细胞支架上的生物大分子含量呈现出不同的结果。亲水性PCL-ECM(F/T)支架通过确保稳定性、良好的细胞相容性以及内皮细胞之间的连接显示出最佳结果,内皮基因表达分析进一步证实了这一点。简而言之,本研究结果可能为构建新型细胞衍生的基于ECM的血管组织工程支架以及开发用于研究内皮细胞功能的体外模型铺平道路。